Hugh Gauch Publishes New Book

 Pre-publication Praise for Scientific Method in Practice:

"In encouraging scientists to examine the basic beliefs and attitudes they share, Gauch provides an enriching journey into a humanities-rich version of science. And because it is a book written by a scientist for scientists, its practical use improves productivity while enriching the experience of discovery."

Marye Anne Fox, Chancellor of North Carolina State University, former President of Sigma Xi (2001–2002), and Chair of the National Research Council Committee on Undergraduate Science Education.

"Written by a scientist for scientists, this is an impressive and comprehensive treatment of the principles of scientific method. Hugh Gauch provides an important, and well-informed, contribution to our contemporary understanding of the practice of science."

Roger Trigg, Professor of Philosophy at the University of Warwick and Chair of the United Kingdom National Committee for Philosophy.

 "Hugh Gauch's discussion of the science wars and the impact this has had on science education is significant and important. Extensive international studies reflect the regrettable consequences of such philosophical diversions. This book helps one understand the issues."

William H. Schmidt, University Distinguished Professor of Education at Michigan State University and National Research Coordinator for the U.S. participation in the Third International Mathematics and Science Study (TIMSS)

"Gauch's claim that a deeper appreciation of the philosophical and theoretical principles undergirding the scientific method would improve the focus, effectiveness and productivity of research scientists is fundamentally sound. Using examples drawn from many fields in science and technology, including pharmacology and clinical medicine, he ably illustrates the relevance and practical benefits of his ideas. This book has much to offer students, educators and professional scientists alike."

Bartholomew J. Votta, Senior Investigator, Department of Musculoskeletal Diseases, GlaxoSmithKline Pharmaceuticals.